Gene · 5885
Papers3,897
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,897
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human transcription factor protein interaction networks. | Nat Commun | 2022 | 35140242 | PubTator, text mining | PubMed |
| Glioma targeted therapy: insight into future of molecular approaches. | Mol Cancer | 2022 | 35135556 | PubTator, text mining | PubMed |
| Genetic polymorphism of ADAM17 and decreased bilirubin levels are associated with allergic march in the Korean population. | BMC Med Genomics | 2022 | 35130903 | PubTator, text mining | PubMed |
| A systematic study of motif pairs that may facilitate enhancer-promoter interactions. | J Integr Bioinform | 2022 | 35130376 | PubTator, text mining | PubMed |
| Anesthetic management of a child with Cornelia de Lange Syndrome undergoing open heart surgery: A case report. | World J Cardiol | 2022 | 35126872 | PubTator, text mining | PubMed |
| ZMIZ2 promotes the development of triple-receptor negative breast cancer. | Cancer Cell Int | 2022 | 35101047 | PubTator, text mining | PubMed |
| spatzie: an R package for identifying significant transcription factor motif co-enrichment from enhancer-promoter interactions. | Nucleic Acids Res | 2022 | 35100401 | PubTator, text mining | PubMed |
| Mutational landscape of circulating tumor DNA identifies distinct molecular features associated with therapeutic response in patients with metastatic colorectal cancer. | Ther Adv Med Oncol | 2022 | 35096147 | PubTator, text mining | PubMed |
| Single Nuclear RNA Sequencing Highlights Intra-Tumoral Heterogeneity and Tumor Microenvironment Complexity in Testicular Embryonic Rhabdomyosarcoma. | J Inflamm Res | 2022 | 35095281 | PubTator, text mining | PubMed |
| Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms. | Leukemia | 2022 | 35091658 | PubTator, text mining | PubMed |
| Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia. | Clin Cancer Res | 2022 | 35091444 | PubTator, text mining | PubMed |
| Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer. | Clin Cancer Res | 2022 | 35091441 | PubTator, text mining | PubMed |
| Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn. | Blood Adv | 2022 | 35090166 | PubTator, text mining | PubMed |
| Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy. | NPJ Precis Oncol | 2022 | 35087175 | PubTator, text mining | PubMed |
| Multimodal regulatory elements within a hormone-specific super enhancer control a heterogeneous transcriptional response. | Mol Cell | 2022 | 35077705 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
| Whole-chromosome arm acquired uniparental disomy in cancer development is a consequence of isochromosome formation. | Neoplasia | 2022 | 35065533 | PubTator, text mining | PubMed |
| Searching for New Z-DNA/Z-RNA Binding Proteins Based on Structural Similarity to Experimentally Validated Zα Domain. | Int J Mol Sci | 2022 | 35054954 | PubTator, text mining | PubMed |
| Keep Calm and Carry on with Extra Centrosomes. | Cancers (Basel) | 2022 | 35053604 | PubTator, text mining | PubMed |
| Super-Enhancers Dysregulations in Hematological Malignancies. | Cells | 2022 | 35053311 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5885/papers?page=54